StonvexLoading…
StonvexStonvexStonvexCore line items from HKIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.54M | $2.90M | $4.56M | $6.43M |
Operating Income | $-1.79M | $-1.75M | $101.06K | $1.63M |
Net Income | $180.14K | $-896.69K | $1.05M | $1.42M |
EPS (Diluted) | $0.02 | $-0.11 | $0.13 | $0.13 |
Total Assets | $42.58M | $41.54M | $35.43M | $21.21M |
Total Liabilities | $6.57M | $6.27M | $7.09M | $7.68M |
Cash & Equivalents | $3.61M | $7.24M | $9.31M | $1.20M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-248.41K | Not available |
Shares Outstanding | 8.61M | 14.39M | 14.39M | 10.99M |